» Articles » PMID: 3967610

[Persistence of Antibodies Against Hepatitis B Surface Antigens After Vaccination Against Hepatitis B]

Overview
Date 1985 Feb 8
PMID 3967610
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In 195 patients vaccinated against hepatitis B the course of anti-HBs concentration was followed over 4 years. Persistence of anti-HBs proved to be dependent on the level of anti-HBs concentration after basal immunization: in 14 subjects with a maximal anti-HBs level between 10 and 100 IU/l the level had dropped to less than 10 IU/l (considered to be the lowest prophylactic concentration), while 7 were anti-HBs negative. Of those who had 101-1000 IU/l after initial immunization 49% had anti-HBs levels under 10 IU/l after 4 years, while 18% were negative. Among subjects with concentrations 1001-10 000 IU/l after the third immunization only 7% had values below 10 IU/l after 4 years, 4.2% were negative. All those who, after the third immunization, had had anti-HBs levels above 10 000 IU/l, 4 years later still had anti-HBs levels of more than 100 IU/l (mean 581 IU/l). Quantitative anti-HBs determination after triple vaccination against hepatitis B thus makes it possible to predict the duration of protection and to determine the timing of re-vaccination.

Citing Articles

Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.

Bucher B, Francioli P, Geudelin B, Fritzell B, Lavanchy D, Frei P Eur J Clin Microbiol Infect Dis. 1994; 13(3):212-7.

PMID: 8050433 DOI: 10.1007/BF01974539.


Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.

Kramer A, HERTH D, von Keyserlingk H, Ludwig W, Hampl H, Sommer D Klin Wochenschr. 1988; 66(15):670-4.

PMID: 2971838 DOI: 10.1007/BF01726924.


German experimental hepatitis B vaccine--influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers.

Kramer A, Sommer D, Hahn E, Riecken E Klin Wochenschr. 1986; 64(15):688-94.

PMID: 2945040 DOI: 10.1007/BF01712053.


Vaccination against hepatitis B--the current situation.

Jilg W, Deinhardt F Infection. 1986; 14(3):100-1.

PMID: 2942487 DOI: 10.1007/BF01643470.


Four-year experience with a recombinant hepatitis B vaccine.

Jilg W, Schmidt M, Deinhardt F Infection. 1989; 17(2):70-6.

PMID: 2714860 DOI: 10.1007/BF01646879.